Concord Biotech CFO to retire early effective Jan 5, 2026
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Smallcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr Lalit Sethi, Chief Financial Officer and Key Managerial Personnel of Concord Biotech, has informed about his early retirement due to personal reasons including family commitments and health, effective close of business hours on January 5, 2026. The trading window for dealing in company securities has been closed from December 8, 2025. He has committed to a seamless handover of financials, compliance and investor relations materials.
CFO exit may cause near term uncertainty. Smooth transition assured; investors will watch for successor appointment announcement.